Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 5 Characteristics of patients who received steroids (n = 10) compared to matched controlled patients (n = 60) who did not received steroidsa

From: Severe varicella-zoster virus pneumonia: a multicenter cohort study

 

No steroid use (n = 60)

Steroids use (n = 10)

p

Demographics

 Age, years

43 (34–56)

48 (35.5–60.75)

0.60

 Male gender

38 (63%)

5 (50%)

0.49

 Co-morbidities

55 (92%)

9 (90%)

1.00

 Underlying immunosuppression

33 (55%)

7 (70%)

0.50

Year of ICU admission

2009 (2006–2012)

2010 (2008–2012)

0.48

Time (days) from dyspnea onset to ICU admission

2 (1–3)

2 (1–3.25)

0.79

Parameters at ICU admission

 Temperature, °C

39.1 (38.25–39.7)

39.4 (38.85–40.8)

0.22

 Respiratory rate, breaths/min

30 (26.5–38.5)

35 (32–35)

0.34

 Oxygen flow, L/min

10 (5–15)

8.5 (1.5–15)

0.55

 Hemoptysis

6 (10%)

0 (0%)

0.58

 PaO2:FiO2 ratio, mmHg

105 (75.5–174.5)

86 (80.5–210)

1.00

 SOFA score at day 1

5 (4–9)

7 (5–7.75)

0.55

ICU management

 Invasive mechanical ventilation

36 (60%)

9 (90%)

0.08

 Time (days) from ICU admission to intubation

1 (1–2)

1 (1–1)

0.30

 ARDS criteria according to the Berlin definition

31 (52%)

7 (70%)

0.33

 Length of invasive mechanical ventilation, days

13.5 (7–17.25)

28 (13–53)

0.06

 Bacterial superinfection

26 (43%)

8 (80%)

0.04

Outcome data

 ICU length of stay, days

10 (4–17)

32 (10.75–69.5)

0.01

 Hospital length of stay, days

16.5 (10–32.25)

40.5 (21.25–74)

0.02

 ICU mortality

12 (20%)

2 (20%)

1.00

 Hospital mortality

15 (25%)

6 (60%)

0.06

  1. Values are shown as n (%) or median (25th–75th percentiles)
  2. aPatients who received steroids were matched in a 1:6 ratio to a control group of patients who did not receive steroids. Matched controls were screened from the current cohort with the following four matching criteria: age, year of ICU admission, SOFA score at day 1, and ARDS criteria according to the Berlin definition
  3. ARDS acute respiratory distress syndrome, ICU intensive care unit, PaO 2 :FiO 2 ratio of arterial oxygen partial pressure to fractional inspired oxygen, SOFA Sequential Organ Failure Assessment